TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Community Occupational Therapy on the Daily Performance of Older Patients With Mild to Moderate Dementia and on the Sense of Competence of Their Primary Caregivers.
Brief Summary: The purpose of this study is to determine the effects of community occupational therapy in older patients with mild ot moderate dementia and their primary caregivers.


Options:
A: Arm Label: Tailored Activity Program; Type: EXPERIMENTAL; Interventions: Other: Tailored Activity Program | Arm Label: Attention Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Attention Control | Intervention Type: OTHER; Name: Tailored Activity Program; Assigned to Arm(s): Tailored Activity Program | Intervention Type: OTHER; Name: Attention Control; Assigned to Arm(s): Attention Control
B: Intervention Type: BEHAVIORAL; Name: community occupational therapy in dementia; Assigned to Arm(s): N/A
C: Arm Label: intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: maintaining of occupational therapy | Arm Label: control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: maintaining of occupational therapy; Assigned to Arm(s): intervention arm
D: Intervention Type: BEHAVIORAL; Name: Home-Based Behavorial Intervention; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Community Occupational Therapy on the Daily Performance of Older Patients With Mild to Moderate Dementia and on the Sense of Competence of Their Primary Caregivers.
Brief Summary: The purpose of this study is to determine the effects of community occupational therapy in older patients with mild ot moderate dementia and their primary caregivers.


Options:
A: Arm Label: Tailored Activity Program; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Activity Program | Arm Label: Home Safety and Education Program; Type: ACTIVE_COMPARATOR; Interventions: Other: Home Safety and Education Program | Intervention Type: BEHAVIORAL; Name: Tailored Activity Program; Assigned to Arm(s): Tailored Activity Program | Intervention Type: OTHER; Name: Home Safety and Education Program; Assigned to Arm(s): Home Safety and Education Program
B: Intervention Type: BEHAVIORAL; Name: community occupational therapy in dementia; Assigned to Arm(s): N/A
C: Arm Label: active tDCS plus real CT; Type: EXPERIMENTAL; Interventions: Device: active tDCS, Behavioral: real CT | Arm Label: sham tDCS plus real CT; Type: EXPERIMENTAL; Interventions: Device: sham tDCS, Behavioral: real CT | Arm Label: active tDCS plus placebo CT; Type: EXPERIMENTAL; Interventions: Device: active tDCS, Behavioral: placebo CT | Arm Label: sham tDCS plus placebo CT; Type: PLACEBO_COMPARATOR; Interventions: Device: sham tDCS, Behavioral: placebo CT | Intervention Type: DEVICE; Name: active tDCS; Assigned to Arm(s): active tDCS plus placebo CT, active tDCS plus real CT | Intervention Type: DEVICE; Name: sham tDCS; Assigned to Arm(s): sham tDCS plus placebo CT, sham tDCS plus real CT | Intervention Type: BEHAVIORAL; Name: real CT; Assigned to Arm(s): active tDCS plus real CT, sham tDCS plus real CT | Intervention Type: BEHAVIORAL; Name: placebo CT; Assigned to Arm(s): active tDCS plus placebo CT, sham tDCS plus placebo CT
D: Intervention Type: BEHAVIORAL; Name: In-home intervention; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
Brief Summary: The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Hydrocortisone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocortisone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Hydrocortisone
B: Intervention Type: DRUG; Name: Mythylprednisolone; Assigned to Arm(s): N/A
C: Arm Label: Experimental Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylprednisolone | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal Saline (0.9%) | Intervention Type: DRUG; Name: methylprednisolone; Assigned to Arm(s): Experimental Group | Intervention Type: DRUG; Name: Normal Saline (0.9%); Assigned to Arm(s): Placebo Group
D: Arm Label: Hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Hydrocortisone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
Brief Summary: The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.


Options:
A: Arm Label: AP301; Type: EXPERIMENTAL; Interventions: Drug: AP301 | Arm Label: saline solution; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline solution | Intervention Type: DRUG; Name: AP301; Assigned to Arm(s): AP301 | Intervention Type: DRUG; Name: Saline solution; Assigned to Arm(s): saline solution
B: Arm Label: Mesenchymal stem cell arm; Type: EXPERIMENTAL; Interventions: Drug: Mesenchymal stem cells | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Mesenchymal stem cells; Assigned to Arm(s): Mesenchymal stem cell arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: N/A
D: Intervention Type: DRUG; Name: Mythylprednisolone; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
Brief Summary: The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.


Options:
A: N/A
B: Intervention Type: DRUG; Name: Mythylprednisolone; Assigned to Arm(s): N/A
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: prone position | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone position; Assigned to Arm(s): A
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: cisatracurium, Drug: Cisatracurium besilate | Intervention Type: DRUG; Name: cisatracurium; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Cisatracurium besilate; Assigned to Arm(s): B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
Brief Summary: The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: cisatracurium, Drug: Cisatracurium besilate | Intervention Type: DRUG; Name: cisatracurium; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Cisatracurium besilate; Assigned to Arm(s): B
B: Intervention Type: DRUG; Name: Mythylprednisolone; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: inspiratory muscle strength training; Assigned to Arm(s): N/A
D: Arm Label: IgM-enriched Intravenous Immunoglobulins; Type: ACTIVE_COMPARATOR; Interventions: Drug: IgM-enriched Intravenous Immunoglobulins | Arm Label: Human Albumin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Human Albumin | Intervention Type: DRUG; Name: IgM-enriched Intravenous Immunoglobulins; Assigned to Arm(s): IgM-enriched Intravenous Immunoglobulins | Intervention Type: DRUG; Name: Human Albumin; Assigned to Arm(s): Human Albumin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Our specific aim is to explore the effect of moderate alcohol intake on parameters of glycemic index and lipid profile among patients with type 2 diabetes.


Options:
A: Arm Label: Low- polyphenol diet; Type: OTHER; Interventions: Other: Two portions of fruit and vegetables per day (excluding berries and dark chocolate) | Arm Label: High-polyphenol diet; Type: ACTIVE_COMPARATOR; Interventions: Other: Six portions of fruit and vegetables per day (one of which must be berries) and 50g dark chocolate. | Intervention Type: OTHER; Name: Two portions of fruit and vegetables per day (excluding berries and dark chocolate); Assigned to Arm(s): Low- polyphenol diet | Intervention Type: OTHER; Name: Six portions of fruit and vegetables per day (one of which must be berries) and 50g dark chocolate.; Assigned to Arm(s): High-polyphenol diet
B: Arm Label: alcohol 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: alcohol | Arm Label: alcohol 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: alcohol | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: alcohol | Intervention Type: DIETARY_SUPPLEMENT; Name: alcohol; Assigned to Arm(s): alcohol 1, alcohol 2, control
C: Intervention Type: DRUG; Name: alcohol; Assigned to Arm(s): N/A
D: Arm Label: Red Wine Polyphenols; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Red Wine Polyphenols 600mg/day | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Red Wine Polyphenols 600mg/day; Assigned to Arm(s): Red Wine Polyphenols | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo; Assigned to Arm(s): placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial on Efficacy and Safety of the Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth (ACG Trial)
Brief Summary: Administration of steroid to the mother in imminent preterm delivery is a known effective practice to decrease the risk of respiratory distress syndrome and intraventricular haemorrhage in preterm infants if given with a week of the preterm delivery. This randomized clinical trial is performed to test the possibility whether the repeat dose of steroid results in further reduction of these diseases in case the mother is in imminent preterm delivery more than a week after the first antenatal steroid treatment.


Options:
A: Intervention Type: DRUG; Name: Betamethasone sodium phos (drug); Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
D: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial on Efficacy and Safety of the Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth (ACG Trial)
Brief Summary: Administration of steroid to the mother in imminent preterm delivery is a known effective practice to decrease the risk of respiratory distress syndrome and intraventricular haemorrhage in preterm infants if given with a week of the preterm delivery. This randomized clinical trial is performed to test the possibility whether the repeat dose of steroid results in further reduction of these diseases in case the mother is in imminent preterm delivery more than a week after the first antenatal steroid treatment.


Options:
A: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
C: Intervention Type: DRUG; Name: Betamethasone sodium phos (drug); Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial on Efficacy and Safety of the Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth (ACG Trial)
Brief Summary: Administration of steroid to the mother in imminent preterm delivery is a known effective practice to decrease the risk of respiratory distress syndrome and intraventricular haemorrhage in preterm infants if given with a week of the preterm delivery. This randomized clinical trial is performed to test the possibility whether the repeat dose of steroid results in further reduction of these diseases in case the mother is in imminent preterm delivery more than a week after the first antenatal steroid treatment.


Options:
A: Intervention Type: DRUG; Name: Betamethasone sodium phos (drug); Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Doxazosin on Ambulatory Blood Pressure and Sympathetic Nervous Activity in Hypertensive Patients With Diabetic Nephropathy
Brief Summary: Few studies have reported the effect of alpha1-adrenergic antagonists on 24-h blood pressure and regulation of sympathetic nervous activity in hypertensive patients with diabetic nephropathy. Using ambulatory blood pressure monitoring devices equipped with spectral analysis of heart rate variability, we assess the effects of doxazosin on blood pressure in diabetic nephropathy patients and compare the results with those in patients with essential hypertension, patients with diabetes mellitus and patients with chronic nephropathy.


Options:
A: Arm Label: Standard glycemic control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Arm Label: Intensive glycemic control; Type: EXPERIMENTAL; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Rosiglitazone; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control
B: Intervention Type: DRUG; Name: Effects of doxazosin on morning surge in diabetic patients; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: aliskiren; Assigned to Arm(s): N/A
D: Arm Label: Atenolol; Type: EXPERIMENTAL; Interventions: Drug: Atenolol | Arm Label: Hydrochlorothiazide (HCTZ); Type: EXPERIMENTAL; Interventions: Drug: Hydrochlorothiazide | Intervention Type: DRUG; Name: Hydrochlorothiazide; Assigned to Arm(s): Hydrochlorothiazide (HCTZ) | Intervention Type: DRUG; Name: Atenolol; Assigned to Arm(s): Atenolol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid, in Premenopausal, Hormone Receptor-positive Breast Cancer Patients (Stage I, II)
Brief Summary: The primary objective is, first, the comparison of tamoxifen and anastrozole and, second, the comparison of zoledronate added to standard adjuvant therapy with controls according to disease-free survival (DFS) in premenopausal patients with non-metastatic breast cancer treated with tamoxifen or anastrozole. To assess whether zoledronate added to standard adjuvant therapy can decrease or even prevent bone loss in patients treated with hormonal blockade combined with an antiestrogen or aromatase inhibitor.


Options:
A: Arm Label: AZ (Arimidex+Zoledronate); Type: ACTIVE_COMPARATOR; Interventions: Drug: anastrozole, Drug: zoledronic acid, Other: goserelin | Arm Label: TZ (Tamoxifen+Zoledronate); Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen, Drug: zoledronic acid, Other: goserelin | Arm Label: AC (Arimidex Control); Type: ACTIVE_COMPARATOR; Interventions: Drug: anastrozole, Other: goserelin | Arm Label: TC (Tamoxifen Control); Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen, Other: goserelin | Intervention Type: DRUG; Name: tamoxifen; Assigned to Arm(s): TC (Tamoxifen Control), TZ (Tamoxifen+Zoledronate) | Intervention Type: DRUG; Name: anastrozole; Assigned to Arm(s): AC (Arimidex Control), AZ (Arimidex+Zoledronate) | Intervention Type: DRUG; Name: zoledronic acid; Assigned to Arm(s): AZ (Arimidex+Zoledronate), TZ (Tamoxifen+Zoledronate) | Intervention Type: OTHER; Name: goserelin; Assigned to Arm(s): AC (Arimidex Control), AZ (Arimidex+Zoledronate), TC (Tamoxifen Control), TZ (Tamoxifen+Zoledronate)
B: Arm Label: Switch to Zoladex + AI for 3-2 years; Type: EXPERIMENTAL; Interventions: Drug: Zoladex+AI | Arm Label: TAM; Type: EXPERIMENTAL; Interventions: Drug: TAM | Intervention Type: DRUG; Name: Zoladex+AI; Assigned to Arm(s): Switch to Zoladex + AI for 3-2 years | Intervention Type: DRUG; Name: TAM; Assigned to Arm(s): TAM
C: Arm Label: TAM+OFS(E) group; Type: EXPERIMENTAL; Interventions: Drug: goserelin, Drug: tamoxifen | Arm Label: TAM(D) group; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen | Arm Label: Permanent postmenopausal(A) group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TAM(B); Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen | Arm Label: TAM+OFS (C); Type: EXPERIMENTAL; Interventions: Drug: goserelin, Drug: tamoxifen | Intervention Type: DRUG; Name: goserelin; Assigned to Arm(s): TAM+OFS (C), TAM+OFS(E) group | Intervention Type: DRUG; Name: tamoxifen; Assigned to Arm(s): TAM(B), TAM(D) group, TAM+OFS (C), TAM+OFS(E) group
D: Arm Label: Combination; Type: EXPERIMENTAL; Interventions: Drug: Goserelin | Arm Label: Conctrol; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen | Intervention Type: DRUG; Name: tamoxifen; Assigned to Arm(s): Conctrol | Intervention Type: DRUG; Name: Goserelin; Assigned to Arm(s): Combination

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid, in Premenopausal, Hormone Receptor-positive Breast Cancer Patients (Stage I, II)
Brief Summary: The primary objective is, first, the comparison of tamoxifen and anastrozole and, second, the comparison of zoledronate added to standard adjuvant therapy with controls according to disease-free survival (DFS) in premenopausal patients with non-metastatic breast cancer treated with tamoxifen or anastrozole. To assess whether zoledronate added to standard adjuvant therapy can decrease or even prevent bone loss in patients treated with hormonal blockade combined with an antiestrogen or aromatase inhibitor.


Options:
A: Arm Label: AZ (Arimidex+Zoledronate); Type: ACTIVE_COMPARATOR; Interventions: Drug: anastrozole, Drug: zoledronic acid, Other: goserelin | Arm Label: TZ (Tamoxifen+Zoledronate); Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen, Drug: zoledronic acid, Other: goserelin | Arm Label: AC (Arimidex Control); Type: ACTIVE_COMPARATOR; Interventions: Drug: anastrozole, Other: goserelin | Arm Label: TC (Tamoxifen Control); Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen, Other: goserelin | Intervention Type: DRUG; Name: tamoxifen; Assigned to Arm(s): TC (Tamoxifen Control), TZ (Tamoxifen+Zoledronate) | Intervention Type: DRUG; Name: anastrozole; Assigned to Arm(s): AC (Arimidex Control), AZ (Arimidex+Zoledronate) | Intervention Type: DRUG; Name: zoledronic acid; Assigned to Arm(s): AZ (Arimidex+Zoledronate), TZ (Tamoxifen+Zoledronate) | Intervention Type: OTHER; Name: goserelin; Assigned to Arm(s): AC (Arimidex Control), AZ (Arimidex+Zoledronate), TC (Tamoxifen Control), TZ (Tamoxifen+Zoledronate)
B: Arm Label: zoledronic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zoledronic Acid | Arm Label: denosumab; Type: EXPERIMENTAL; Interventions: Biological: Denosumab | Intervention Type: BIOLOGICAL; Name: Denosumab; Assigned to Arm(s): denosumab | Intervention Type: DRUG; Name: Zoledronic Acid; Assigned to Arm(s): zoledronic acid
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid | Intervention Type: DRUG; Name: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel; Assigned to Arm(s): A | Intervention Type: DRUG; Name: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid; Assigned to Arm(s): B
D: Intervention Type: DRUG; Name: zoledronic acid; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: adjuvant therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: neoadjuvant therapy; Assigned to Arm(s): N/A

Answer: A